EROC compared with PLSE: revenue, margins and what each company keeps, and the suppliers and customers both name

EROCERock, Inc.

Mkt capRevenueRevenue

PLSEPulse Biosciences, Inc.

Mkt capRevenueRevenue

Compare

EROCERock, Inc.

PLSEPulse Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EROC

No earnings history for EROC.

PLSE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.7%▲+10.90%×0.93

Q1 FY26±21.7%▼−3.84%×0.18

Feb 20 '26±19.0%▼−14.59%×0.77

Q3 FY25±28.5%▼−3.32%×0.12

= impliedEROC realized, solidPLSE realized, hatchedOne scale, both sides: full bar = 29%× = |realized| ÷ impliedSource: market data

EROCERock, Inc.

6.65▼−16.26%· post 6.62· delayed

Mkt cap$382.5MRevenue$40MQ2 FY26

PLSEPulse Biosciences, Inc.

52.94▼−7.23%· post 52.94· delayed

After hoursNov 5 '26delayed

Mkt cap$4.1BRevenue$434,000Q2 FY26

Compare

After hoursNov 5 '26delayed

EROCERock, Inc.

PLSEPulse Biosciences, Inc.

6.65▼−16.26%post 6.62delayed

Price

52.94▼−7.23%post 52.94delayed

$382.5M

Mkt cap

$4.1B

Q2 FY26$40M

Revenue

$434,000Q2 FY26

EROC6.65▼−16.26%vsPLSE52.94▼−7.23%After hoursNov 5 '26delayed